Compare BEAT & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BEAT | FSEA |
|---|---|---|
| Founded | 2015 | 1890 |
| Country | United States | United States |
| Employees | 16 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Savings Institutions |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.2M | 61.5M |
| IPO Year | N/A | 2022 |
| Metric | BEAT | FSEA |
|---|---|---|
| Price | $1.16 | $12.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | ★ 827.3K | 1.2K |
| Earning Date | 03-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $260.78 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.54 | $10.13 |
| 52 Week High | $4.00 | $15.00 |
| Indicator | BEAT | FSEA |
|---|---|---|
| Relative Strength Index (RSI) | 36.54 | 44.64 |
| Support Level | $0.91 | $11.44 |
| Resistance Level | $1.35 | $13.00 |
| Average True Range (ATR) | 0.09 | 0.16 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 16.47 | 6.15 |
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.